Better Responses Seen With Booster mRNA COVID-19 Vaccine in Pregnancy
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 18, 2023 -- Robust antibody responses to mRNA COVID-19 vaccines are detected in boosted pregnant individuals, according to a study published in the Aug. 14 issue of Vaccine.
Flor M. Munoz, M.D., from the Baylor College of Medicine in Houston, and colleagues conducted a prospective cohort study of participants vaccinated during pregnancy with primary or booster COVID-19 vaccines from July 2021 to January 2022 at nine academic sites. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binding and live virus and pseudovirus neutralizing antibody (nAb) titers were determined prevaccination and postvaccination and at delivery for maternal and infant participants. In maternal sera at delivery and in cord blood, immune responses to ancestral and omicron BA.1 SARS-CoV-2 strains were compared for primary and booster vaccine recipients.
Two hundred forty participants received a Pfizer or Moderna mRNA vaccine during pregnancy (167 primary series; 73 booster). The researchers found that significantly higher binding and nAb titers, including to the omicron BA.1 variant, resulted from booster vaccination compared with the primary two-dose series in both maternal sera at delivery and in cord blood. At delivery, live virus nAb to omicron BA.1 were present in 9 and 22 percent of Pfizer and Moderna primary series recipients, respectively, and in 73 percent of boosted participants. For all regimens, transplacental antibody transfer was efficient.
"Our study supports that COVID-19 vaccination, and particularly booster doses, should be strongly recommended during pregnancy for maternal and neonatal protection," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
Some Children Prescribed Nonrecommended Meds for COVID-19
MONDAY, May 13, 2024 -- Despite national guidelines, a small proportion of children were prescribed ineffective and potentially harmful medications for acute COVID-19, according...
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Long-Term Smell, but Not Taste, Deficits Seen After COVID-19
WEDNESDAY, May 1, 2024 -- Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.